To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
118th Congress
Introduced Jun 8, 2023
Sponsors
Legislative Progress
Introduced
Introduced
Committee
Passed
Jun 8, 2023
Mr. Braun (for himself, Mrs. Gillibrand, Mr. Wicker, Mr. Cramer, …
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology